HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adrienne H Brouwers Selected Research

1- (4- isothiocyanatobenzyl)diethylenetriaminepentaacetic acid

2/2004Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Adrienne H Brouwers Research Topics

Disease

42Neoplasms (Cancer)
10/2022 - 08/2003
11Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 12/2012
9Renal Cell Carcinoma (Grawitz Tumor)
08/2019 - 08/2003
7Breast Neoplasms (Breast Cancer)
01/2022 - 02/2012
7Neuroendocrine Tumors (Neuroendocrine Tumor)
09/2021 - 09/2008
4Disease Progression
10/2022 - 09/2005
4Melanoma (Melanoma, Malignant)
01/2021 - 10/2009
4Carcinoid Tumor (Carcinoid)
10/2011 - 07/2005
3Neoplasm Metastasis (Metastasis)
06/2022 - 07/2011
2Squamous Cell Carcinoma of Head and Neck
10/2022 - 01/2010
2Primary Hyperparathyroidism
07/2019 - 11/2017
2Sarcoma (Soft Tissue Sarcoma)
06/2018 - 06/2018
2Atrial Fibrillation
12/2017 - 12/2015
2von Hippel-Lindau Disease (von Hippel Lindau Disease)
01/2016 - 05/2012
2Insulinoma
01/2015 - 01/2011
2Islet Cell Adenoma (Islet Cell Tumors)
05/2012 - 03/2008
2Pheochromocytoma
01/2010 - 03/2009
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2022
1Bone Resorption
11/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Parathyroid Neoplasms (Parathyroid Neoplasm)
07/2019
1Protein-Losing Enteropathies (Protein-Losing Enteropathy)
01/2019
1Adenocarcinoma
01/2019
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
12/2013

Drug/Important Bio-Agent (IBA)

9Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2022 - 10/2009
7Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2008
7Pharmaceutical PreparationsIBA
08/2019 - 01/2008
789Zr-bevacizumabIBA
01/2017 - 08/2007
6Dihydroxyphenylalanine (Dopa)IBA
06/2022 - 09/2009
6Monoclonal AntibodiesIBA
08/2019 - 02/2004
6CatecholaminesIBA
08/2019 - 07/2005
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 08/2007
6Proteins (Proteins, Gene)FDA Link
01/2015 - 02/2004
5fluorodopa F 18IBA
03/2021 - 03/2008
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 09/2009
4ThyroglobulinFDA Link
01/2019 - 08/2013
4Bevacizumab (Avastin)FDA Link
01/2015 - 08/2007
3Radioisotopes (Radionuclides)IBA
06/2022 - 09/2003
3Trastuzumab (Herceptin)FDA Link
01/2022 - 07/2010
3IodineIBA
01/2022 - 08/2013
3Tumor Biomarkers (Tumor Markers)IBA
03/2021 - 01/2011
3G250 monoclonal antibodyIBA
08/2019 - 09/2003
3AntibodiesIBA
01/2017 - 09/2005
3EverolimusFDA Link
01/2017 - 01/2011
2Somatostatin Receptors (Somatostatin Receptor)IBA
06/2022 - 03/2008
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
06/2022 - 03/2021
2Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
11/2021 - 05/2016
2EnzymesIBA
09/2021 - 07/2013
2ErbB Receptors (EGF Receptor)IBA
10/2017 - 07/2010
2InterferonsIBA
01/2015 - 08/2003
2Sunitinib (Sutent)FDA Link
01/2015 - 01/2011
2zirconium-89-trastuzumabIBA
08/2014 - 02/2012
2Serotonin (5 Hydroxytryptamine)IBA
10/2011 - 03/2008
2Phenylalanine (L-Phenylalanine)FDA Link
09/2008 - 03/2008
2AntigensIBA
09/2003 - 08/2003
1B7-H1 AntigenIBA
10/2022
1durvalumabIBA
10/2022
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
06/2022
1Peptide Receptors (Peptide Receptor)IBA
06/2022
1Collagen Type I (Type I Collagen)IBA
11/2021
1OsteocalcinIBA
11/2021
1collagen type I trimeric cross-linked peptideIBA
11/2021
1Peptide Hydrolases (Proteases)FDA Link
10/2021
1Peptides (Polypeptides)IBA
10/2021
1Carboxy-LyasesIBA
09/2021
1Alanine (L-Alanine)FDA Link
09/2021
1Dopamine (Intropin)FDA LinkGeneric
09/2021
1Amino AcidsFDA Link
09/2021
1Ga(III)-DOTATOCIBA
03/2021
1FluorineIBA
01/2021
1AminesIBA
08/2019
1Carcinoembryonic AntigenIBA
01/2019
1MCOIBA
01/2019
1Immune Checkpoint InhibitorsIBA
12/2018
1LigandsIBA
12/2018
1atezolizumabIBA
12/2018
1Programmed Cell Death 1 ReceptorIBA
12/2018
1Levodopa (L Dopa)FDA LinkGeneric
08/2018
1lumretuzumabIBA
10/2017
1pro-brain natriuretic peptide (1-76)IBA
08/2017
1Indicators and Reagents (Reagents)IBA
01/2017
1Biological ProductsIBA
01/2015
1Glucagon-Like Peptide-1 ReceptorIBA
01/2015
1Estrogen ReceptorsIBA
08/2014
15- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
08/2014
1Somatotropin Receptors (Growth Hormone Receptor)IBA
10/2013
1Thyroxine (Levothyroxine)FDA LinkGeneric
08/2013

Therapy/Procedure

12Therapeutics
06/2022 - 01/2008
3Immunotherapy
08/2008 - 08/2003
3Radioimmunotherapy
10/2005 - 02/2004
2Thyroidectomy
12/2015 - 01/2015
1PET protocol
07/2019
1Roux-en-Y Anastomosis (Anastomosis, Roux en Y)
01/2019
1Liver Transplantation
01/2019
1Radiotherapy
06/2018
1Parathyroidectomy
11/2017
1Precision Medicine
01/2017
1Aftercare (After-Treatment)
12/2015
1Intravenous Administration
07/2013